Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gerresheimer AGCHIX:GXID 66 14-Day RSI is 99.62 as of Jul. 29, 2026. GuruFocus rates CHIX:GXID with a GF Score™ of 66/100 and a GF Value™ of €103.17 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Gerresheimer AG ranks better than 56.12% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-29), Gerresheimer AG's 14-Day RSI is 99.62.
The industry rank for Gerresheimer AG's 14-Day RSI or its related term are showing as below:
CHIX:GXId's 14-Day RSI is ranked better than 56.12% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: 45.715
vs CHIX:GXId: 99.62
Gerresheimer AG (CHIX:GXId) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Gerresheimer AG 14-Day RSI Related Terms
CHIX:GXID vs ISRG, BDX, MDLN: 14-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's 14-Day RSI falls into.
Gerresheimer AG (CHIX:GXId) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (CHIX:GXID) has a 14-Day RSI of 99.62 as of Jul. 29, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Gerresheimer AG and its competitors. According to the industry distribution chart, Gerresheimer AG ranks #380 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 43.9%.
Is Gerresheimer AG's 14-Day RSI too high?
Gerresheimer AG's current 14-Day RSI is 99.62. The Medical Devices & Instruments industry median 14-Day RSI is 45.72. Gerresheimer AG's value of 99.62 is 117.9% above this industry median. Based on the distribution chart, Gerresheimer AG ranks #380 out of 866 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Gerresheimer AG has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's 14-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #380 out of 866 companies for 14-Day RSI. This puts Gerresheimer AG in the upper half of its industry. The industry median 14-Day RSI is 45.72. Gerresheimer AG's value of 99.62 is 117.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 45.72, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current 14-Day RSI of 99.62 is 117.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 45.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current 14-Day RSI is 99.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (CHIX:GXID) is currently considered Possible Value Trap. The stock's GF Value™ is €103.17, compared to a current price of €27.75 — trading 73.1% below its estimated fair value. The current 14-Day RSI is 99.62 and 117.9% above the Medical Devices & Instruments industry median of 45.72. Gerresheimer AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Gerresheimer AG (CHIX:GXID), the current 14-Day RSI is 99.62 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (CHIX:GXID) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of €27.75 is trading 73.1% below its estimated GF Value™ of €103.17.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for CHIX:GXID:
14-Day RSI: 99.62
GF Value™: €103.17 vs. price of €27.75 (73.1% below fair value)
Industry Position: 117.9% above the Medical Devices & Instruments median (#380 of 866)
No single metric tells the full story. See the CHIX:GXID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
66GF Score
Get the complete analysis for CHIX:GXID
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:GXID has been successfully added to your 
